Dendritic cell-based therapy with immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dendritic cell-based therapy with immunotherapy, covering 2025-01-29 to 2025-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer [Phase 2]